VAP-1, a Novel Molecule Linked to Endothelial Damage and Kidney Function in Kidney Allograft Recipients

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Serum Vascular Adhesion Protein-1 Predicts 10-Year Cardiovascular and Cancer Mortality in Individuals With Type 2 Diabetes

(2011) Hung-Yuan Li et al.   DIABETES

A structure–activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme

(2010) Emanuela Bonaiuto et al.   BIOCHIMIE

Mechanism of endothelial dysfunction in chronic kidney disease

(2010) Jolanta Malyszko   CLINICA CHIMICA ACTA

SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders

(2010) Josep Mercader et al.   Future Medicinal Chemistry

Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia

(2009) Hung-Yuan Li et al.   CLINICA CHIMICA ACTA

Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects

(2009) Hung-Yuan Li et al.   CLINICA CHIMICA ACTA

Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes

(2009) Kousuke Noda et al.   EXPERIMENTAL EYE RESEARCH

Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease

(2008) Mao-Shin Lin et al.   CLINICAL BIOCHEMISTRY

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET